Results 211 to 220 of about 5,946,577 (342)
Raphin‐1 reduces the survival of PED‐DHGG cells and enhances their radiation sensitivity through both PeIF2α‐dependent and PeIF2α‐independent mechanisms. Raphin‐1 sustains elevated levels of PeIF2α, contributing to its PeIF2α‐dependent effects. Additionally, raphin‐1 interacts with CReP to mediate a separate radiosensitizing pathway that operates ...
Karin Eytan+4 more
wiley +1 more source
Point-of-Care Ultrasound in the Diagnosis of Pott's Puffy Tumor in a Pediatric Patient. [PDF]
Shahid S+3 more
europepmc +1 more source
The HemoCue®, a point of care B-hemoglobin photometer, measures hemoglobin concentrations accurately when mixedin vitro with canine plasma and three hemoglobin-based oxygen carriers (HBOC) [PDF]
Jonathan S. Jahr+5 more
openalex +1 more source
In prostate carcinoma, lactic acid, secreted by highly glycolytic cancer‐associated fibroblasts, is imported into tumor cells through the MCT1 transporter and prevents RSL3 and erastin‐induced ferroptosis (A). Targeting of carbonic anhydrase IX/XII, the main extracellular pH regulators, in tumor and stromal cells reduces microenvironmental acidosis and
Elisa Pardella+18 more
wiley +1 more source
Technologies for the point-of-care diagnosis of malaria: a scoping review. [PDF]
Coro F+3 more
europepmc +1 more source
Bringing evidence to the point of care: what do clinicians want?
Sharon E. Straus+3 more
openalex +1 more source
Reducing Potential Medical Errors in Point-of-Care Testing [PDF]
Gerald J. Kost+5 more
openalex +1 more source
This study presents a novel AI‐based diagnostic approach—comprehensive serum glycopeptide spectra analysis (CSGSA)—that integrates tumor markers and enriched glycopeptides from serum. Using a neural network model, this method accurately distinguishes liver and pancreatic cancers from healthy individuals.
Motoyuki Kohjima+6 more
wiley +1 more source
Transformative impact of point-of-care testing in critical care. [PDF]
Dabla PK, Dabas A.
europepmc +1 more source